Naftopidil
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Trade names | Flivas |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration |
Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.220.557 |
| Chemical and physical data | |
| Formula | C24H28N2O3 |
| Molar mass | 392.499 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Naftopidil (INN, marketed under the brand name Flivas) is a drug used in benign prostatic hypertrophy which acts as a selective α1-adrenergic receptor antagonist or alpha-1 blocker.
See also
|
Sympatholytics (antagonize α-adrenergic vasoconstriction) |
|||||
|---|---|---|---|---|---|
| Other antagonists |
|
||||
| |||||
| α1 |
|
||||
|---|---|---|---|---|---|
| α2 |
|
||||
| β |
|
||||